Micron Q2 FY2026 Earnings — Peak Cycle Stress Test
Scenario Comparison
Q2 revenue >$19.5B (beats consensus $19.15B), Q3 FY2026 guided >$18.5B with GM >62%, management confirms shortage extends through CY2027+
HBM revenue exceeds $4B in Q2 (>21% of total), management provides HBM4 ramp details; addresses Samsung three-vendor competitive dynamics
Q2 revenue <$18.3B (misses guidance lower bound), margin miss, or management lowers FY2026 outlook
All Scenarios
7Positioning Suggestions
→ MU at $447 (~12x P/B): EXTREME CAUTION. Base case target $340 implies -24% downside. PW expected return approximately -25%. Even a beat may be sell-the-news given 4-quarter beat streak and Polymarket pricing 97.55% beat probability. Do NOT add. Consider trimming if Q3 guide disappoints.
→ AMAT: Read MU capex guidance closely. Tongluo acquisition + second facility could push total capex >$22B. If confirmed, validates AMAT's 'WFE super cycle' thesis. Lam (LRCX) has higher beta to memory capex.
→ LRCX: Highest beta play on MU capex. If capex guidance raised >$22B, Lam benefits most given ~50% DRAM etch share. But also highest risk if guidance is soft.
→ SNDK: Watch NAND commentary — MU's NAND guidance is the highest-signal data point for SNDK's recovery thesis. If NAND inventory normalized + ASPs rising → SNDK bull case strengthens.
→ SKHynix: Cross-reference MU's HBM share commentary with SKHynix's mid-50% allocation. Samsung HBM4 competition commentary affects both MU and SKHynix positioning.
→ Risk management: At $447 the asymmetry is severely negative. A beat is priced in. A miss or soft guide could trigger -10 to -15% move. Earnings are a binary event where the downside convexity far exceeds the upside at this price.
Predictions
15MU Q2 FY2026 revenue will exceed the $18.7B guidance midpoint
Expected — the real question is magnitude. Beat by >$500M validates cycle strength.
MU Q2 FY2026 revenue will exceed consensus $19.15B (beat the street, not just guidance)
If consensus beat → stock may rally despite elevated valuation. If miss consensus but beat guide → sell-the-news risk at $447.
MU Q2 FY2026 non-GAAP EPS will exceed consensus $8.69 per share
Beat history (14.4% avg surprise) strongly supports this. Key is whether beat magnitude approaches Most Accurate Estimate of $9.19.
Q3 FY2026 revenue guidance midpoint will be >$18.0B (extending the peak-cycle narrative)
If confirmed → bull confirmation; if guided <$17B → cycle peak thesis validated, consider trimming memory exposure
Q3 FY2026 gross margin guidance will be >60% (sustained peak margins through HBM mix)
If confirmed → HBM margin premium sustaining despite three-vendor competition; positive for SKHynix read-through
MU will report HBM revenue exceeding $3.5B in Q2 FY2026 (>19% of total revenue)
If confirmed → validates HBM structural demand thesis; positive for AMKR/ASE packaging volumes
Management will provide explicit Samsung HBM4 competitive commentary (acknowledging three-vendor market dynamics)
If Samsung pricing pressure mentioned → increase bear scenario probability; watch for defensive tone vs confident tone
FY2026 capex guidance will be revised upward from $20B to >$21B (reflecting Tongluo $1.8B acquisition)
If confirmed → strong positive for AMAT and LRCX (direct WFE demand); but raises MU operating leverage risk
Tongluo site will be specifically mentioned in prepared remarks with FY2028 production timeline details
Near-certain given 3/15 completion. Watch for any timeline acceleration to FY2027.
DRAM contract pricing commentary will indicate Q2 CY2026 QoQ increase decelerating to <30% (from 90-95% in Q1)
If deceleration steeper than expected → signals cycle peak; tighten stop-loss on memory positions
MU will report data center revenue mix exceeding 60% of total revenue (up from 56% in Q1 FY2026)
If confirmed → structural mix shift narrative strengthens; higher floor for trough margins vs prior cycles
MU stock will move more than 8% (either direction) on earnings day or the following session
MU stock will close BELOW $447 (current price) on earnings day despite beating guidance (sell-the-news)
At $447 with 97.55% Polymarket beat probability, a beat is priced in. Watch Q3 guide as the swing factor.
MU will announce NAND inventory normalization is complete with enterprise SSD ASPs rising
If confirmed → positive for SNDK (NAND recovery thesis validated)
At least one Wall Street analyst will downgrade MU within 48 hours of earnings (sell-the-news at peak valuation)
Key Questions
- Q3 FY2026 revenue and GM guidance — is the cycle extending or peaking? >$18B/62% = bull, <$17B/55% = bear
- HBM revenue quantum and trajectory — $3.5B? $4B+? Acceleration rate vs Q1 FY2026 ~$2B?
- HBM4 ramp status — yield, ASP premium vs HBM3E, and customer qualification timeline
- DRAM contract pricing guidance for Q2 CY2026 — magnitude of QoQ deceleration from 90-95%?
- Samsung HBM4 competitive commentary — acknowledging three-vendor market? Any pricing pressure?
- NAND pricing and inventory levels — has the NAND channel fully normalized?
- FY2026 capex update — impact of Tongluo $1.8B acquisition + second facility on total capex?
- Tongluo + Idaho fab production timeline — confirms FY2028 output or any acceleration?
- Data center revenue mix — above 60%? (was 56% in Q1 FY2026 after Crucial exit)
- Customer concentration — any commentary on NVIDIA dependency or diversification to AMD/hyperscalers?
- Any update on CXMT competitive threat in trailing-edge DRAM?
Monitoring Checklist
Post-Event Results
Actual Outcomes
- • Retrospective card scoring, 2026-08-27. This event completed without any postAnalysis, so its 15 prediction cards had never been scored and nothing in the pipeline would have picked them up. 14 resolved against evidence dated after the event, 1 left unresolvable. Mean Brier 0.2675. Cards only: no analysis, no thesis impact and no trade actions are reconstructed here, because doing that with hindsight would fabricate a judgement nobody made at the time.